文献速递临床微生物质量管理与危急值

韩国2018至2022年沙门菌血清型分布及耐药性

Serotype Distribution and Antimicrobial Resistance of Salmonella in Korea Between 2018 and 2022.
PubMed 文献 · Ann Lab Med · 2025-12-18

该研究分析了韩国9所大学医院2018至2022年分离的965株沙门菌,鉴定出58种血清型,最常见为肠炎沙门菌(21.5%)和I 4,[5],12:i:-(20.7%),对氨苄西林耐药率33.2%,环丙沙星中介耐药率32.8%,多重耐药率6.2%,广泛耐药率2.0%。结论强调需持续监测沙门菌血清型及耐药性以指导临床管理。

要点

  • 韩国沙门菌以肠炎沙门菌和I 4,[5],12:i:-为主,前10种血清型占79.4%。
  • 对氨苄西林耐药率33.2%,环丙沙星中介耐药率达32.8%。
  • 多重耐药率6.2%,广泛耐药率2.0%,需持续监测。

核心结论

  • 持续监测沙门菌血清型及抗菌药物耐药性对患者管理是必要的。

研究设计与样本

  • 研究纳入韩国9所大学医院2018至2022年分离的965株沙门菌。
  • 采用Kauffmann-White方案进行血清分型,使用Sensititre KRCDC2F药敏板进行抗菌药物敏感性试验。

主要发现

  • 965株中732株(75.9%)来自粪便标本,233株(24.1%)来自血液标本,共鉴定出58种血清型。
  • 最常见血清型为肠炎沙门菌(207株,21.5%)、I 4,[5],12:i:-(200株,20.7%)、婴儿沙门菌(88株,9.1%)、巴雷利沙门菌(77株,8.0%)和鼠伤寒沙门菌(69株,7.2%)。
  • 对氨苄西林、氯霉素、甲氧苄啶-磺胺甲噁唑、头孢噻肟和头孢曲松的耐药率分别为33.2%、11.1%、8.2%、8.6%和8.3%。
  • 对环丙沙星耐药率为3.0%,中介耐药率为32.8%;肠炎沙门菌环丙沙星非敏感率为93.7%,甲型副伤寒沙门菌环丙沙星耐药率为83.3%,伤寒沙门菌广泛耐药率为10.0%。
  • 总体多重耐药率为6.2%(60株),广泛耐药率为2.0%(19株)。

临床怎么用

  • 临床应关注沙门菌血清型分布及耐药趋势,尤其是环丙沙星中介耐药率高,经验用药需参考本地监测数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Salmonella is one of the main pathogens causing food-borne infectious diseases. We investigated the serotype distribution and antimicrobial resistance of Salmonella isolates in Korea obtained between 2018 and 2022. METHODS: We studied 965 Salmonella isolates from nine university hospitals across Korea. Serotypes were determined following the Kauffmann-White scheme, and antimicrobial susceptibility tests were performed using Sensititre KRCDC2F susceptibility testing plates. RESULTS: Of the 965 isolates, 732 (75.9%) were isolated from stool specimens, and 233 (24.1%) were isolated from blood specimens. We identified 58 different serotypes. The five most frequent serotypes detected were S. serovar Enteritidis (N=207; 21.5%), S. serovar I 4,[5],12:i:- (N=200; 20.7%), S. serovar Infantis (N=88; 9.1%), S. serovar Bareilly (N=77; 8.0%), and S. serovar Typhimurium (N=69; 7.2%). The 10 most common serotypes accounted for 79.4% of all isolates. The resistance rates to ampicillin, chloramphenicol, trimethoprim-sulfamethoxazole, cefotaxime, and ceftriaxone were 33.2%, 11.1%, 8.2%, 8.6%, and 8.3%, respectively. Although only 3.0% of Salmonella isolates were resistant to ciprofloxacin, the intermediate resistance rate was 32.8%. We observed ciprofloxacin non-susceptibility (93.7%) in S. Enteritidis, ciprofloxacin resistance (83.3%) in S. serovar Paratyphi A, and extensive drug resistance (10.0%) in S. serovar Typhi. The overall rates of multidrug and extensive drug resistance were 6.2% (N=60) and 2.0% (N=19), respectively. CONCLUSIONS: Continuous monitoring of Salmonella serotypes for antimicrobial resistance is necessary for appropriate patient management.

来源:Ann Lab Med,查看原文。版权归原作者所有。

引用

  1. Kim SM, Kim SH, Kim EY, et al. Serotype Distribution and Antimicrobial Resistance of Salmonella in Korea Between 2018 and 2022. Ann Lab Med. 2025. PMID: 41408861. doi:10.3343/alm.2025.0412

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。